Sparks commentary - PVA TePla

TMT

Sparks - PVA TePla

More on this equity
PVA TePla (SCALE:TPE) reports H1 results
Published by Edwin De Jong

In PVA TePla’s H1 results, sales increased 7% to €135.3m and EBITDA increased 26% to €21.9m. Metrology equipment sales were particularly high in the quarter, certainly in ultrasound microscopy especially for advanced packaging. PVA expects order momentum in the semiconductor industry to pick up in Q4, which we believe is an important signal. The company confirmed the FY24 forecast for sales of Є270-290m and EBITDA of €47-51m.

Latest

Healthcare | Comment

Herantis Pharma (HEL: HRTIS) – a step closer to Phase II

Investment Companies | Comment

The Biotech Growth Trust (BIOG) reported encouraging H126 results

TMT | Comment

Nanoco (LSE:NANO) settles LG litigation for $5m

Healthcare | Comment

Mendus (OMX: IMMU) announces c SEK50m directed share issue